| REGISTERED NUMBER: |
| FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 APRIL 2024 |
| FOR |
| TRADING SCIENCE LIMITED |
| REGISTERED NUMBER: |
| FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 APRIL 2024 |
| FOR |
| TRADING SCIENCE LIMITED |
| TRADING SCIENCE LIMITED (REGISTERED NUMBER: 04074348) |
| CONTENTS OF THE FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 30 APRIL 2024 |
| Page |
| Company Information | 1 |
| Statement of Financial Position | 2 |
| Notes to the Financial Statements | 4 |
| TRADING SCIENCE LIMITED |
| COMPANY INFORMATION |
| FOR THE YEAR ENDED 30 APRIL 2024 |
| DIRECTORS: |
| SECRETARY: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| ACCOUNTANTS: |
| Chartered Accountants |
| 232 Sladepool Farm Road |
| Birmingham |
| B14 5EE |
| TRADING SCIENCE LIMITED (REGISTERED NUMBER: 04074348) |
| STATEMENT OF FINANCIAL POSITION |
| 30 APRIL 2024 |
| 2024 | 2023 |
| Notes | £ | £ | £ |
| FIXED ASSETS |
| Tangible assets | 5 |
| Investments | 6 |
| CURRENT ASSETS |
| Debtors | 7 |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year | 8 |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CREDITORS |
| Amounts falling due after more than one year |
9 |
( |
) |
( |
) |
| PROVISIONS FOR LIABILITIES | ( |
) |
| NET ASSETS |
| CAPITAL AND RESERVES |
| Called up share capital | 11 |
| Retained earnings |
| SHAREHOLDERS' FUNDS |
| The directors acknowledge their responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| TRADING SCIENCE LIMITED (REGISTERED NUMBER: 04074348) |
| STATEMENT OF FINANCIAL POSITION - continued |
| 30 APRIL 2024 |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| TRADING SCIENCE LIMITED (REGISTERED NUMBER: 04074348) |
| NOTES TO THE FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 30 APRIL 2024 |
| 1. | STATUTORY INFORMATION |
| Trading Science Limited is a |
| 2. | STATEMENT OF COMPLIANCE |
| 3. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| The company's functional and presentation currency is the pound sterling, rounded to the nearest £. |
| Significant judgements and estimates |
| In preparing these financial statements the company's management make judgements, estimates and assumptions that affect the amounts reported for assets and liabilities at the statement of financial position date and the amounts reported in the income statement for the year under review. |
| The nature of estimates means that the actual outcome could differ and the company's management consider there are no estimates or assumptions that have a significant risk of causing a material adjustment to the amounts reported for assets and liabilities within the next financial year. |
| Turnover |
| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
| Tangible fixed assets |
| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life. |
| Plant and machinery etc. | - | 20% on cost and 25% on reducing balance |
| Tangible fixed assets are initially recorded at cost. |
| Financial instruments |
| Basic financial assets and liabilities are initially recognised at transaction price and are subsequently measured at amortised cost. |
| Taxation |
| Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the current or past reporting periods. It is measured at the amount expected to be paid or recovered using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date. |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date. |
| Research and development |
| Expenditure on research and development is written off in the year in which it is incurred. |
| TRADING SCIENCE LIMITED (REGISTERED NUMBER: 04074348) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 30 APRIL 2024 |
| 3. | ACCOUNTING POLICIES - continued |
| Foreign currencies |
| Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result. |
| Hire purchase and leasing commitments |
| Assets obtained under hire purchase contracts or finance leases are capitalised in the statement of financial position and are depreciated over their estimated useful lives. The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability. |
| Pension costs and other post-retirement benefits |
| The company contributes to defined contribution pension schemes. Contributions payable by the company are charged to profit or loss in the period to which they relate. |
| Employee benefits |
| When employees have rendered service to the company, short-term employee benefits to which the employees are entitled are recognised at the amount expected to be paid in exchange for that service. |
| 4. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the year was |
| 5. | TANGIBLE FIXED ASSETS |
| Plant and |
| machinery |
| etc |
| £ |
| COST |
| At 1 May 2023 |
| and 30 April 2024 |
| DEPRECIATION |
| At 1 May 2023 |
| Charge for year |
| At 30 April 2024 |
| NET BOOK VALUE |
| At 30 April 2024 |
| At 30 April 2023 |
| TRADING SCIENCE LIMITED (REGISTERED NUMBER: 04074348) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 30 APRIL 2024 |
| 6. | FIXED ASSET INVESTMENTS |
| Other |
| investments |
| £ |
| COST |
| At 1 May 2023 |
| and 30 April 2024 |
| NET BOOK VALUE |
| At 30 April 2024 |
| At 30 April 2023 |
| 7. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Trade debtors |
| Other debtors |
| Prepayments and accrued income |
| 8. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Bank loans and overdrafts |
| Other loans |
| Hire purchase contracts |
| Trade creditors |
| Taxation and social security |
| Accruals and deferred income |
| 9. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Bank loan - 1 to 2 years |
| Bank loan - 2 to 5 years |
| Hire purchase contracts |
| 10. | SECURED DEBTS |
| The following secured debts are included within creditors: |
| 2024 | 2023 |
| £ | £ |
| Hire purchase contracts |
| Certain other loans were secured by a fixed and floating charge over the company's assets. Hire purchase liabilities are secured by a charge over the tangible fixed asset concerned. |
| TRADING SCIENCE LIMITED (REGISTERED NUMBER: 04074348) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 30 APRIL 2024 |
| 11. | CALLED UP SHARE CAPITAL |
| Allotted, issued and fully paid: |
| Number: | Class: | Nominal | 2024 | 2023 |
| value: | £ | £ |
| Ordinary | £0.01 | 29,000 |
| Ordinary B | £0.01 | 21,000 |
| 50,000 | 50,000 |
| The rights attaching to the ordinary B shares vary from those attaching to the ordinary shares in respect of voting rights only, ordinary B shares carrying one vote for every three shares held. Ordinary shares carry one vote for every share held. |
| During the previous financial year the company granted additional share options to certain of its employees. At the statement of financial position date, the share options relate in total to 210,000 ordinary B shares of £0.01 each and can be exercised in accordance with the rules of each scheme or earlier at the sole discretion of the company's Board of Directors. |